This book explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines.
Obijiofor Aginam is Senior Academic Officer at United Nations University Institute for Sustainability and Peace, Tokyo, Japan; John Harrington is Professor of Law at Cardiff University, Wales, UK; and Peter K. Yu is Kern Family Chair in Intellectual Property Law, Drake University Law School, US.
Obijiofor Aginam and John Harrington
2. Communitarian Globalism and Disease: A Normative Orientation for Global Health Governance
3. Is AIDS Treatment Sustainable?
Kenneth C. Shadlen
4. Access to Paediatric Medicines: The Global Political Economy of Drug Production and Supply forChildren in the Developing World
Avram Denburg and Kelley Lee
5. Trade Agreements, Intellectual Property and Access to Essential Medicines: What Future Role for the Right to Health?
6. Re-visiting the Patents and Access to Medicines Dichotomy: An Evaluation of TRIPs Implementation and Public Health Safeguards in Developing Countries
7. Seizure of Generic Pharmaceuticals in Transit Based on Allegations of Patent Infringement: A Threat to International Trade, Development and Public Welfare
Frederick M. Abbott
8. Patent Licensing Strategies for the Research and Development of Pharmaceuticals in Developing Countries
Gail E. Evans
9. Increasing Access through Incentives for Innovation: The Health Impact Fund
10. Building IPC4D to Promote Access to Essential Medicines
Peter K. Yu
11. The Global Governance of HIV/AIDS and the Rugged Road Ahead: An Epilogue
Peter K. Yu